Determining the Efficiency of Single Molecule Quantum Dot Labeling of HER2 in Breast Cancer Cells.

fluorescence microscopy labeling efficiency liquid-phase electron microscopy membrane protein nanoparticle single-molecule analysis

Journal

Nano letters
ISSN: 1530-6992
Titre abrégé: Nano Lett
Pays: United States
ID NLM: 101088070

Informations de publication

Date de publication:
11 11 2020
Historique:
pubmed: 10 10 2020
medline: 25 6 2021
entrez: 9 10 2020
Statut: ppublish

Résumé

Quantum dots exhibit unique properties compared to other fluorophores, such as bright fluorescence and lack of photobleaching, resulting in their widespread utilization as fluorescent protein labels in the life sciences. However, their application is restricted to relative quantifications due to lacking knowledge about the labeling efficiency. We here present a strategy for determining the labeling efficiency of quantum dot labeling of HER2 in overexpressing breast cancer cells. Correlative light- and liquid-phase electron microscopy of whole cells was used to convert fluorescence intensities into the underlying molecular densities of the quantum dots. The labeling procedure with small affinity proteins was optimized yielding a maximal labeling efficiency of 83%, which was applicable to the high amount of ∼1.5 × 10

Identifiants

pubmed: 33034459
doi: 10.1021/acs.nanolett.0c02644
doi:

Substances chimiques

Fluorescent Dyes 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

7948-7955

Auteurs

Diana B Peckys (DB)

Molecular Biophysics, Center for Integrative Physiology and Molecular Medicine, Saarland University, 66421 Homburg, Germany.

Cedric Quint (C)

Department of Physics, Saarland University, 66123 Saarbrücken, Germany.

Niels de Jonge (N)

Department of Physics, Saarland University, 66123 Saarbrücken, Germany.
INM - Leibniz Institute for New Materials, 66123 Saarbrücken, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH